Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Clin Microbiol Infect ; 22(8): 711-4, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27297319

ABSTRACT

Mycoplasma pneumoniae is a leading cause of respiratory disease. In the Intensive Care Unit (ICU) setting M. pneumoniae is not considered a common pathogen. In 2010-13 an epidemic of M. pneumoniae-associated infections was reported and we observed an increase of M. pneumoniae patients admitted to ICU. We analysed the cohort of all M. pneumoniae-positive patients' admissions during 2007 to 2012 at the Hadassah-Hebrew University Medical Centre (a 1100-bed tertiary medical centre). Mycoplasma pneumoniae diagnosis was made routinely using PCR on throat swabs and other respiratory samples. Clinical parameters were retrospectively extracted. We identified 416 M. pneumoniae-infected patients; of which 68 (16.3%) were admitted to ICU. Of these, 48% (173/416) were paediatric patients with ICU admission rate of 4.6% (8/173). In the 19- to 65-year age group ICU admission rate rose to 18% (32/171), and to 38.8% (28/72) for patients older than 65 years. The mean APACHE II score on ICU admission was 20, with a median ICU stay of 7 days, and median hospital stay of 11.5 days. Of the ICU-admitted patients, 54.4% (37/68) were mechanically ventilated upon ICU admission. In 38.2% (26/68), additional pathogens were identified mostly later as secondary pathogens. A concomitant cardiac manifestation occurred in up to 36.8% (25/68) of patients. The in-hospital mortality was 29.4% (20/68) and correlated with APACHE II score. Contrary to previous reports, a substantial proportion (16.3%) of our M. pneumoniae-infected patients required ICU admission, especially in the adult population, with significant morbidity and mortality.


Subject(s)
Intensive Care Units , Mycoplasma pneumoniae , Patient Admission , Pneumonia, Mycoplasma/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Hospital Mortality , Humans , Male , Middle Aged , Pneumonia, Mycoplasma/diagnosis , Pneumonia, Mycoplasma/microbiology , Pneumonia, Mycoplasma/mortality , Population Surveillance , Retrospective Studies , Risk Factors , Severity of Illness Index , Young Adult
2.
Rev Esp Quimioter ; 29(4): 220-3, 2016 Aug.
Article in Spanish | MEDLINE | ID: mdl-27305511

ABSTRACT

OBJECTIVE: To standardize the relative quantification by mass of tissue parasitism by Demodex folliculorum infestation from neoplastic skin biopsies periocular using molecular amplification to study the possible relationship of the appearance of eyelid basal cell carcinoma with the presence and density of the mite in later works. METHODS: A quantitative PCR was developed real-time probes TaqMan. PCR was tested in a pilot 46 actual biopsy samples nodular basal cell carcinoma series. RESULTS: The sensitivity was placed with a detection limit of between 1 and 10 copies / µl. 50% (23/46) of the biopsies were positive for D. folliculorum. The specificity was 100% confirmed by sequencing. CONCLUSIONS: The technique shows good results for sensitivity and specificity that can make it useful as a tool for studies of cause and effect D. folliculorum and basal cell carcinoma.


Subject(s)
Carcinoma, Basal Cell/parasitology , Mite Infestations/parasitology , Mites/genetics , Polymerase Chain Reaction/methods , Skin Neoplasms/parasitology , Animals , Biopsy/methods , Carcinoma, Basal Cell/complications , Humans , Sensitivity and Specificity , Skin/parasitology , Skin Neoplasms/complications
3.
Euro Surveill ; 18(18): 20471, 2013 May 02.
Article in English | MEDLINE | ID: mdl-23725776

ABSTRACT

Following a bloodstream infection in June 2011 with Ralstonia mannitolilytica in a premature infant treated with a humidifying respiratory therapy device, an investigation was initiated at the Hadassah Medical Centres in Jerusalem. The device delivers a warmed and humidified mixture of air and oxygen to patients by nasal cannula. The investigation revealed colonisation with R. mannitolilytica of two of 15 patients and contamination of components of five of six devices deployed in the premature units of the Hadassah hospitals. Ten isolates from the investigation were highly related and indistinguishable from isolates described in an outbreak in 2005 in the United States (US). Measures successful in containing the US outbreak were not included in user instructions provided to our hospitals by the distributor of the device.


Subject(s)
Equipment Contamination , Gram-Negative Bacterial Infections/etiology , Humidity , Oxygen Inhalation Therapy/instrumentation , Ralstonia pickettii/isolation & purification , Respiratory Tract Infections/etiology , Anti-Bacterial Agents/therapeutic use , Colistin/therapeutic use , Disease Outbreaks/statistics & numerical data , Disinfection/methods , Drug Resistance, Bacterial , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/epidemiology , Gram-Negative Bacterial Infections/microbiology , Humans , Humidity/adverse effects , Infant, Newborn , Infant, Premature , Israel/epidemiology , Oxygen Inhalation Therapy/adverse effects , Ralstonia pickettii/growth & development , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/microbiology
4.
Euro Surveill ; 17(8)2012 Feb 23.
Article in English | MEDLINE | ID: mdl-22401504

ABSTRACT

A substantial epidemic of Mycoplasma pneumonia infection was reported in late 2011 in some European countries. We report here an epidemic of M. pneumonia infection that began in Jerusalem during 2010 and is still ongoing. This report complements current information on what might be a worldwide epidemic of M. pneumoniae infection that might require substantial coordinated international public health intervention.


Subject(s)
Mycoplasma Infections/diagnosis , Mycoplasma Infections/epidemiology , Mycoplasma pneumoniae/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Epidemics , Female , Hospitals, Teaching , Humans , Infant , Infant, Newborn , Israel/epidemiology , Length of Stay , Male , Middle Aged , Mycoplasma Infections/microbiology , Real-Time Polymerase Chain Reaction , Young Adult
5.
J Clin Microbiol ; 45(10): 3456-8, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17699655

ABSTRACT

We describe a case of Pichia farinosa bloodstream infection in a lymphoma patient. Phenotypic methods failed to identify the isolate, which was identified by sequence-based methods. This case highlights the importance of implementing molecular methods for the identification of rare fungal pathogens.


Subject(s)
Fungemia/microbiology , Lymphoma, Large B-Cell, Diffuse/complications , Pichia/isolation & purification , Adolescent , Humans , Male , Pichia/classification , Pichia/genetics
6.
Rev Cubana Med Trop ; 51(1): 20-5, 1999.
Article in Spanish | MEDLINE | ID: mdl-10887551

ABSTRACT

A genomic expression library of Trypanosoma cruzi (T. cruzi) was made using plasmid pcDNA3 as a vector, with which male mice from the Balb/c isogenic line were intramuscullary inoculated. It was used a positive control group that was administered soluble antigens of T. cruzi. Other 2 groups received genomic and plasmid DNA, respectively. One group was not immunized. Weekly blood samples were obtained from all the animals until the fourth week and 2 weeks after reimmunization to study the response of specific antibodies against the microorganism antigens by an indirect immunoenzymatic assay (ELISA). It was observed a significant increase of specific antibodies in the animals reimmunized with 50 micrograms of the library, as well as in the group immunized with soluble antigens of T. cruzi.


Subject(s)
Antibodies, Protozoan/biosynthesis , Antibodies, Protozoan/genetics , DNA, Protozoan/genetics , Genomic Library , Trypanosoma cruzi/genetics , Animals , DNA, Protozoan/administration & dosage , Immunoglobulin G/immunology , Male , Mice , Mice, Inbred BALB C
SELECTION OF CITATIONS
SEARCH DETAIL
...